학술논문

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
Document Type
Article
Source
In: British Journal of Cancer. (British Journal of Cancer, 19 March 2013, 108(5):1052-1060)
Subject
Language
English
ISSN
00070920
15321827